Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0043167 (pertussis)
 19,595 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The influence of 3 batches of live parotitis vaccine from strain L-3 on the organism of 2,536 vaccinated children of preschool and junior school age was studied. The injection of this preparation was shown to induce weak and moderate systemic reactions on the average in 0.8% of the children and local hyperemia of the skin in 7.8% of the children during the first 2-4 days. No severe reactions and complications were observed. Parotitis vaccine induced the weak specific and nonspecific allergic transformation of the organism, did not significantly increase the frequency of aberrant metaphases in the lymphocyte culture, did not essentially influence the frequency of intercurrent diseases at the proximate (21 days) and remote (1 year) periods after immunization, did not suppress the intensity of postvaccinal immunity to pertussis, diphtheria and tetanus. Though various batches of the vaccine showed no sharp differences in their influence on the organism, nevertheless postvaccinal reactions were found to be more frequent, and intercurrent diseases occurred more rarely in the children immunized with the batch containing 20,000 HADU50.
 ...
PMID:[Safety, antigenic activity, and epidemiologic effectiveness of live mumps vaccine from strain Leningrad-3. I. Reactogenic, allergenic and mutagenic properties of the vaccine and its effect on the body's resistance to intercurrent diseases]. 723 45

Bacteriological, pharmacokinetic and clinical studies on SY5555 dry syrup (powder which is dissolved before use), a new penem antibiotic for oral use, were performed. The following results were obtained. 1. Antibacterial activities. MICs of SY5555, clavulanic acid/amoxicillin (CVA/AMPC), cefotiam (CTM), cefpodoxime (CPDX), cefaclor (CCL) and cefdinir (CFDN) were determined against clinically isolated Staphylococcus aureus, coagulase negative staphylococci, Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, Moraxella catarrhalis, Escherichia coli and Enterobacter cloacae at a dose of 10(6) CFU/ml. MICs of SY5555 against S. aureus, CNS, S. pneumoniae, S. pyogenes, H. influenzae, M. catarrhalis, E. coli and E. cloacae were 0.2, 0.2, 0.2, < or = 0.025, 0.78, 0.2, 0.78 and 3.13 micrograms/ml, respectively, showing excellent antibacterial effects on these pathogens. Although the effects of SY 5555 against H. influenzae and E. coli were slightly inferior to those of CPDX and CFDN, the drug showed the most excellent antibacterial effect on other strains as compared with the control drugs. 2. Absorption and excretion In this study, plasma concentrations and urinary recovery rates were examined after administration of SY5555 at doses of 5 and 10 mg/kg (potency) after meals. With both 5 and 10 mg/kg doses, peak plasma concentrations were reached 1 hour after administration, at 0.25-2.61 micrograms/ml (mean 1.47 micrograms/ml) and 1.08-2.17 micrograms/ml (mean 1.74 micrograms/ml), respectively. The plasma levels rapidly decreased to 0.06-0.19 micrograms/ml (0.12 micrograms/ml) and 0.0503-0.0637 micrograms/ml) after 6 hours. The half-lives 1.12 hours in the 5 mg/kg group and 1.0 hour in the 10 mg/kg group. The urinary recovery rates were determined in the first 8 hours after administration in the 5 mg/kg and 6 hours in the 10 mg/kg group, and the values were as low as 1.05-12.3% and 1.6-4.33%, respectively. 3. Clinical results The clinical responses were examined in a total of 73 cases including 4 acute pneumonia, 13 acute bronchitis, 11 tonsillitis, 3 pharyngitis, 12 scarlet fever, 2 pertussis, 6 urinary tract infection, 6 otitis media, 7 lymphadenitis, 2 staphylococcal scalded skin syndrome, 2 phlegmon, 4 impetigo and 1 purulent parotitis. The treatment was effective or better in 66 of 70 cases with an efficacy rate of 94.3% (3 undeterminable cases were excluded). Bacteriological effects were examined during the clinical course for detected or suspected pathogens found before administration of SY5555. The effects were determined in 50 cases including 7 cases of polymicrobacterial infections, 57 strains in total. Eight strains, however, persisted, hence the overall eradication rate was 86.0%.(ABSTRACT TRUNCATED AT 400 WORDS)
 ...
PMID:[Bacteriological, pharmacokinetic and clinical studies of SY5555 dry syrup in the pediatric field]. 769 46

Primary health care of preschool children is organized in the Republic of Croatia by pediatricians, general practitioners and family/general practice specialist. The aim of this study is to evaluate the care for preschool children in the well baby clinics led by general/family specialist. Vaccination and visits data were collected from the medical records of 148 children born from January 1st 1992 till December 31st 1997, registered in two family practice offices in the well baby clinics at the Dugave-Travno Health Station of the "Novi Zagreb" Health Center. Comparison was made between data on compulsory immunization minimum in the Republic of Croatia and data from the Croatian National Institute of Public Health on vaccination of infants and preschool children in the Republic of Croatia in 1997. Diphtheria, tetanus and poliomyelitis vaccination was 100%, pertussis vaccination was 97.2%, measles and parotitis vaccination was 92.2% and rubella vaccination was 91.5%. Diphtheria and tetanus revaccination of children in the second year of life was 97.6%, pertussis revaccination was 94.4% and poliomyelitis revaccination was 96.8%. Comparison of those results proves the efficacy of compulsory immunization program of preschool children in family/general specialists' offices. The accessibility of general/family practice, appropriate education of general/family specialists during the specialization in family medicine for primary care of preschool children as well as for other family members, the ability of family physician to offer integrated continuous care and good cooperation of the family physician and the public nurse are the factors that enable appropriate primary care for preschool children in general practice/family medicine.
 ...
PMID:[Family practitioners in the primary health care of preschool-age children--a report on well-child care in the practice of 2 family medicine physicians]. 1093 29